Artificial insemination is a process where active and mobile sperm are prepared by separating them from the seminal fluid and then injecting directly through the cervix into the uterus and the fallopian tubes.
Vitrolife Business Development director Tony Winslof said the reason that they are now choosing to try to develop products for this part of the infertility market is to increase the value of IUI within assisted fertilization through more effective treatment.